These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10360607)

  • 1. Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience.
    Latreille J; Gelmon KA; Hirsh V; Laberge F; Maksymiuk AW; Shepherd FA; Delorme F; Bérille J
    Invest New Drugs; 1998-1999; 16(3):265-70. PubMed ID: 10360607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
    Belani CP; Einzig A; Bonomi P; Dobbs T; Capozzoli MJ; Earhart R; Cohen LJ; Luketich JD
    Ann Oncol; 2000 Jun; 11(6):673-8. PubMed ID: 10942054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial.
    Gandara DR; Vokes E; Green M; Bonomi P; Devore R; Comis R; Carbone D; Karp D; Belani C
    J Clin Oncol; 2000 Jan; 18(1):131-5. PubMed ID: 10623703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel in stage III and IV non-small cell lung cancer.
    Rigas JR
    Eur J Cancer; 1995; 31A Suppl 4():S18-20. PubMed ID: 7577100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
    Le Chevalier T; Bérille J; Zalcberg JR; Millward MJ; Monnier A; Douillard JY; McKeage MJ; James R; Soulas F; Loret C; Bougon N; Bizzari JP
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):13-8. PubMed ID: 10458205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
    Chen YM; Shih JF; Lee CS; Chen MC; Lin WC; Tsai CM; Perng RP
    Lung Cancer; 2003 Feb; 39(2):209-14. PubMed ID: 12581575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
    Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
    Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.
    Zalcberg J; Millward M; Bishop J; McKeage M; Zimet A; Toner G; Friedlander M; Barter C; Rischin D; Loret C; James R; Bougan N; Berille J
    J Clin Oncol; 1998 May; 16(5):1948-53. PubMed ID: 9586914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.
    Mattson K; Bosquee L; Dabouis G; Le Groumellec A; Pujol JL; Marien S; Stupp R; Douillard JY; Brägas B; Berille J; Olivares R; Le Chevalier T
    Lung Cancer; 2000 Sep; 29(3):205-16. PubMed ID: 10996423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.
    Miller VA; Rigas JR; Francis PA; Grant SC; Pisters KM; Venkatraman ES; Woolley K; Heelan RT; Kris MG
    Cancer; 1995 Feb; 75(4):968-72. PubMed ID: 7842417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of docetaxel in advanced non-small cell lung cancer.
    Saarinen A; Jekunen A; Halme M; Pyrhönen S; Tamminen K; Boyer R; Roubille N; Mattson K
    Anticancer Drugs; 1996 Nov; 7(8):890-2. PubMed ID: 8991195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
    Francis PA; Rigas JR; Kris MG; Pisters KM; Orazem JP; Woolley KJ; Heelan RT
    J Clin Oncol; 1994 Jun; 12(6):1232-7. PubMed ID: 7911159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
    Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM
    Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel: a review of its use in non-small cell lung cancer.
    Comer AM; Goa KL
    Drugs Aging; 2000 Jul; 17(1):53-80. PubMed ID: 10933515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.
    Kunitoh H; Watanabe K; Onoshi T; Furuse K; Niitani H; Taguchi T
    J Clin Oncol; 1996 May; 14(5):1649-55. PubMed ID: 8622084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese experience with second-line chemotherapy with low-dose (60 mg/M2) docetaxel in patients with advanced non-small-cell lung cancer.
    Mukohara T; Takeda K; Miyazaki M; Takifuji N; Terakawa K; Negoro S
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):356-60. PubMed ID: 11761452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer.
    Goh BC; Lehnert M; Lim HL; Ng AW; Chan CC; Kong HL; Lee SC; Wee J; Chua ET; Wong JE
    Acta Oncol; 2000; 39(2):225-9. PubMed ID: 10859016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma.
    Lilenbaum RC; Schwartz MA; Seigel L; Belette F; Blaustein A; Wittlin FN; Davila E
    Cancer; 2001 Oct; 92(8):2158-63. PubMed ID: 11596033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI; Kancharla K; Qamar R; Fisher S; Hantel A; Panganiban J; Millbrandt L; Albain KS
    Lung Cancer; 2001 Nov; 34(2):271-7. PubMed ID: 11679186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study.
    Pectasides D; Visvikis A; Kouloubinis A; Glotsos J; Bountouroglou N; Karvounis N; Ziras N; Athanassiou A
    Eur J Cancer; 2002 Jun; 38(9):1194-200. PubMed ID: 12044505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.